Trypanothione reductase from Trypanosoma cruzi

Tryanothione reductase of Trypanosoma cruzi is a key enzyme in the antioxidant metabolism of the parasite. Here we report on the enzymic and pharmacological properties of trypanothione reductase using glutathionylspermidine disulfide as a substrate. 1 Both pH optimum (7.5) and the ionic strength optimum (at 30 mM) are unusually narrow for this enzyme. 40 mM Hepes, 1 mM EDTA, pH 7.5 was chosen as a standard assay buffer because in this system the kcat/Km ratio had the highest values for both natural substrates, glutathionylspermidine disulfide (2.65 × 106 M–1 s–1) and trypanothione disulfide (4.63 × 106 M–1 s–1). 2 Using the standardized assay, trypanothione reductase and the phylogenetically related host enzyme, human glutathione reductase, were studied as targets of inhibitors. Both enzymes, in their NADPH-reduced forms, were irreversibly modified by the cytostatic agent, 1,3-bis(2-chloreethyl)-1-nitrosourea (BCNU). Nifurtimox, the drug used in the treatment of Chagas' disease, is a stronger inhibitor of glutathione reductase (Ki= 40μM) than of trypanothione reductase (IC50= 200 μM). 3 Of the newly synthesized trypanocidal compounds [Henderson, G. B., Ulrich, P., Fairlamb, A. H., Rosenberg, I., Pereira, M., Sela, M. & Cerami, A. (1988) Proc. Natl Acad. Sci., 85, 5374–5378] a nitrofuran derivative, 2-(5-nitro-2-furanylmethylidene)-N,N′ - [1,4-piperazinediylbis (1,3-propanediyl)]bishydrazinecarboximidamide tetrahydrobromide, was found to be a better inhibitor for trypanothione reductase (Ki= 0.5 μM) than for glutathione reductase (IC50= 10μM). A naphthoquinone derivative, 2,3-bis[3-(2-amidinohydrazono)-butyl]-1,4-naphthoquinone dihydrochloride, turned out to be both an inhibitor (IC50= 1 μM) and an NADPH-oxidation-inducing substrate (Km= 14 μM). This effect was not observed with human glutathione reductase. Such compounds which lead to oxidative stress by more than one mechanism in the parasite are promising starting points for drug design based on the three-dimensional structures of glutathione and trypanothione reductases.

[1]  G. Ellman,et al.  Tissue sulfhydryl groups. , 1959, Archives of biochemistry and biophysics.

[2]  A. Pirie,et al.  The production of superoxide radicals in reactions of the herbicide diquat. , 1971, FEBS letters.

[3]  B. Mannervik.  A branching reaction mechanism of glutathione reductase. , 1973, Biochemical and biophysical research communications.

[4]  M. Rosemeyer,et al.  Human glutathione reductase: purification of the crystalline enzyme from erythrocytes. , 1974, European journal of biochemistry.

[5]  C. W. Tabor,et al.  Isolation, characterization, and turnover of glutathionylspermidine from Escherichia coli. , 1975, The Journal of biological chemistry.

[6]  G. Schulz,et al.  Crystals of human erythrocyte glutathione reductase , 1975, FEBS letters.

[7]  David J. Worthington,et al.  Glutathione Reductase from Human Erythrocytes , 1976 .

[8]  B. Mannervik,et al.  Purification by affinity chromatography of yeast glutathione reductase, the enzyme responsible for the NADPH-dependent reduction of the mixed disulfide of coenzyme A and glutathione. , 1977, Biochimica et biophysica acta.

[9]  G. H. Coombs,et al.  Biochemistry of Parasitic Protozoa , 1977 .

[10]  O. Zwisler,et al.  Biochemical and technical considerations regarding the mass production of certain parasitic protozoa. , 1977, Bulletin of the World Health Organization.

[11]  R. Schirmer,et al.  Glutathione reductase from human erythrocytes. Isolation of the enzyme and sequence analysis of the redox-active peptide. , 1977, European journal of biochemistry.

[12]  B. Mannervik,et al.  Inhibition of glutathione reductase by interaction of 2,4,6‐trinitrobenzenesulfonate with the active‐site dithiol , 1979, FEBS letters.

[13]  R. Docampo,et al.  Generation of superoxide anion and hydrogen peroxide induced by nifurtimox in Trypanosoma cruzi. , 1979, Archives of biochemistry and biophysics.

[14]  H. Sies,et al.  Deficient metabolic utilization of hydrogen peroxide in Trypanosoma cruzi. , 1980, The Biochemical journal.

[15]  B. Mannervik,et al.  Oxidase activity of glutathione reductase effected by 2,4,6‐trinitrobenzenesulfonate , 1980, FEBS letters.

[16]  R. Schirmer,et al.  Glutathione reductase from human erythrocytes: amino-acid sequence of the structurally known FAD-binding domain. , 1981, European journal of biochemistry.

[17]  B. Halliwell,et al.  Formation of hydroxyl radicals from the paraquat radical cation, demonstrated by a highly specific gas chromatographic technique. the role of superoxide radical anion, hydrogen peroxide, and glutathione reductase. , 1982, Journal of inorganic biochemistry.

[18]  A. Fairlamb.  Biochemistry of trypanosomiasis and rational approaches to chemotherapy , 1982 .

[19]  R. Schirmer,et al.  Glutathione reductase from human erythrocytes. The sequences of the NADPH domain and of the interface domain. , 1982, European journal of biochemistry.

[20]  R. Docampo,et al.  Increased biliary secretion and loss of hepatic glutathione in rat liver after nifurtimox treatment. , 1983, Biochemical pharmacology.

[21]  G. Schulz,et al.  The catalytic mechanism of glutathione reductase as derived from x-ray diffraction analyses of reaction intermediates. , 1983, The Journal of biological chemistry.

[22]  G. Schulz,et al.  Interaction of a glutathione S-conjugate with glutathione reductase. Kinetic and X-ray crystallographic studies. , 1984, European journal of biochemistry.

[23]  R. Docampo,et al.  Free radical metabolites in the mode of action of chemotherapeutic agents and phagocytic cells on Trypanosoma cruzi. , 1984, Reviews of infectious diseases.

[24]  B. Chait,et al.  Trypanothione: a novel bis(glutathionyl)spermidine cofactor for glutathione reductase in trypanosomatids. , 1985, Science.

[25]  M. Agosin,et al.  A cytosolic flavin-containing enzyme catalyzing reduction of cytochrome c in Trypanosoma cruzi: kinetic studies with cytochrome c as substrate. , 1985, Archives of biochemistry and biophysics.

[26]  M. Agosin,et al.  A cytosolic FAD-containing enzyme catalyzing cytochrome c reduction in Trypanosoma cruzi. I. Purification and some properties. , 1985, Archives of biochemistry and biophysics.

[27]  Wim G. J. Hol.  Proteinkristallographie und Computer-Graphik – auf dem Weg zu einer planvollen Arzneimittelentwicklung , 1986 .

[28]  A. Fairlamb,et al.  The biosynthesis of trypanothione and N1-glutathionylspermidine in Crithidia fasciculata. , 1986, Molecular and biochemical parasitology.

[29]  A. Fairlamb,et al.  Synthesis of the trypanosomatid metabolites trypanothione, and N1-mono- and N8-mono-glutathionylspermidine , 1986 .

[30]  A. Fairlamb,et al.  Purification and characterization of trypanothione reductase from Crithidia fasciculata, a newly discovered member of the family of disulfide-containing flavoprotein reductases. , 1986, Biochemistry.

[31]  R. Klein,et al.  Hydrogen peroxide metabolism in Trypanosoma brucei. , 1986, Molecular and biochemical parasitology.

[32]  R. Perham,et al.  Glutathione reductase from Escherichia coli: cloning and sequence analysis of the gene and relationship to other flavoprotein disulfide oxidoreductases. , 1986, Biochemistry.

[33]  A. Fairlamb,et al.  Substrate specificity of the flavoprotein trypanothione disulfide reductase from Crithidia fasciculata. , 1987, Biochemistry.

[34]  R. Schirmer,et al.  Oxidative stress as a defense mechanism against parasitic infections. , 1987, Free radical research communications.

[35]  B. E. Kimmel,et al.  Trypanothione reductase of Trypanosoma congolense: gene isolation, primary sequence determination, and comparison to glutathione reductase. , 1988, Biochemistry.

[36]  A. Fairlamb,et al.  "Subversive" substrates for the enzyme trypanothione disulfide reductase: alternative approach to chemotherapy of Chagas disease. , 1988, Proceedings of the National Academy of Sciences of the United States of America.